1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-24-295

PAR-24-295National Institutes of HealthK43

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Oct 15, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 9 standing review criteria here, free with an account. Create free account

Summary

This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.

Related NIH announcements1

Companion announcements with the same title first, then other open K43 announcements on related subjects with at least two weeks to go.

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

PAR-24-296National Institutes of Health8 review criteria on fileagency framework

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 9 standing review criteria National Institutes of Health applies to this kind of proposal (its standard framework, not criteria written for this announcement)

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

RFA-DK-27-108National Institutes of Health3 review criteria on fileagency framework

$500k

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Clinical research), with at least two weeks to apply.

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-188National Institutes of Health3 review criteria on file

$500k

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

PAR-25-062National Institutes of Health6 review criteria on file

—

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

RFA-AI-27-002National Institutes of Health

—

Everything open tagged Clinical research

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.